Nestlé Developing Microbiome-Based Supplements with Dutch Partner

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

Bacteria cells
• Source: Shutterstock

Nestle Health Science SA has entered into a strategic collaboration with Netherlands-based Caelus Health to develop microbiome-based food supplements for the prevention and early treatment of cardio-metabolic diseases.

Under the terms of a global development and option agreement signed by both firms, Nestlé has agreed to fund Caelus’...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation & IP

Over The Counter: How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten

 
• By 

HBW Insight catches up with PA Consulting's personalization and consumer expert Rhea Patten to find out what “vibes” are and how understanding this aspect of “consumer centricity” better can help consumer health companies grow their brands.

Beauty Supplement Containing Herring Cast Out Across Europe, Asia

 
• By 

Arctic Bioscience says its supplement based on herring roe oil "supports the skin’s beauty and vitality from within."

Get To Know: Desert Harvest Targets Bacteria Causing Gap In Urinary Tract Health

 

Launching Heather’s UTI Defense, firm partners with Oxford University in clinical trial comparing its supplement head-to-head with D-mannose, most commonly available dietary ingredient for UTI prevention

OptiBiotix Enters US Supplements Market With Hydroxycut

 
• By 

UK's OptiBiotix believes its SlimBiome probiotic can cut through in the crowded US market for weight loss supplements.

More from Wellness

NPA Expects FDA Answer On NMN Citizen Petition Could Trigger Drug Preclusion Policy Challenge

 

NPA will learn not only if it will need to continue litigation seeking to force change should FDA reject its petition for deeming NMN a dietary ingredient, but also if agency acknowledges industry’s questions about the agency’s drug preclusion regulation.

Over The Counter: How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten

 
• By 

HBW Insight catches up with PA Consulting's personalization and consumer expert Rhea Patten to find out what “vibes” are and how understanding this aspect of “consumer centricity” better can help consumer health companies grow their brands.

‘FDA Approved’ Not An Ad Claim Infant Formula Can Use, NAD Review Finds

 

NAD attorneys find Kendal Nutricare can continue using “natural” ad claims with limits for Kendamil formula but also conclude some research it submitted to support other claims wasn’t appropriate because the studies didn’t test its products.